Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sugen (SUGN) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (368)	4/5/1999 10:52:00 AM
From: Mike K	Read Replies (1) \| Respond to of 550

David; I like and own both. I have a small position in CELG stock and have sold 50 put contracts at various prices and expiry dates. I have a somewhat larger position in SUGN and have also sold May 17 1/2 puts. Looking at selling more SUGN puts today. With all the hype of the last week, premiums are much more attractive. BTW, I am a multiple myeloma patient, who looking at both companies very closely. My illness is very early stage and I am currently enrolled in a phase 1 gene therapy trial. Thalidomide is a drug that I will definitely consider down the road. SUGN is also conducting a phase 1 trial of SU5416 which includes multiple myeloma patients at Royal Marsden Hospital in London and the Arizona Cancer Center. Cheers, Mike